Author:
Rivière Pierre,Penel Nicolas,Faure Karine,Marie Guillaume,Najem Abeer,Rivière Marie-Karelle,Panaget Sophie
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference33 articles.
1. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review;Mackall;Stem Cells Dayt Ohio,2000
2. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis Off Publ Infect Dis Soc Am. févr 2014;58(3):309–18.
3. HCSP. Vaccination des personnes immunodéprimées ou aspléniques. Recommandations actualisées. [Internet]. Rapport de l’HCSP. Paris: Haut Conseil de la Santé Publique; 2014 nov [cité 4 mai 2020]. Disponible sur: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=504.
4. The burden of influenza complications in different high-risk groups: a targeted literature review;Mauskopf;J Med Econ,2013
5. Beck CR, McKenzie BC, Hashim AB, Harris RC, University of Nottingham Influenza and the ImmunoCompromised (UNIIC) Study Group,, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis. 2012;206(8):1250–9.